Skip to main content
. 2022 Sep 17;23(18):10901. doi: 10.3390/ijms231810901

Figure 3.

Figure 3

Effects of RD-genes knockdown on MDA-MB-231 CFU and viability. (a) Representative image showing CFU potential of MDA-MB-231 cells on day 7 post transfection with siRNA targeting ELOB, SLC39A7, TIMM13, BANF1, NDUFS1, NDUFB7, TRAPPC5, and MVD as a single treatment modality or in combination with doxorubicin (10 nM) or paclitaxel (10 nM). (b) Quantification of CFU from two independent experiments. Data are presented as the mean ± S.E., n = 6. * p < 0.05, ** p < 0.005, *** p < 0.0005, n.s.: not significant. Each treatment was compared to the corresponding control condition.